Telomerase activation in adenocarcinoma-bronchioloalveolar carcinoma

Brambilla E., Lantuejoul S.

Source: Eur Respir J 2006; 27: 1079-1081
Journal Issue: June
Disease area: Thoracic oncology

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Brambilla E., Lantuejoul S.. Telomerase activation in adenocarcinoma-bronchioloalveolar carcinoma. Eur Respir J 2006; 27: 1079-1081

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Telomerase expression in lung tumors
Source: Eur Respir J 2003; 22: Suppl. 45, 198s
Year: 2003

Telomerase activation in a model of lung adenocarcinoma
Source: Eur Respir J 2006; 27: 1175-1182
Year: 2006



Angiogenic squamous dysplasia: highly associated with squamous cell lung carcinoma
Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Year: 2006

COX-2 expression during early lung squamous cell carcinomas oncogenesis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

Bilateral squamous cell carcinoma
Source: Annual Congress 2008 - Various thoracic tumours and interesting cases
Year: 2008

Expression of miR-126 and miR-126* in primary tumors and metastasis of adenocarcinoma and squamous carcinoma of the lung
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

Human bronchogenic carcinoma cell-asociated VEGF-expression in balb-c-nunu mice
Source: Eur Respir J 2001; 18: Suppl. 33, 232s
Year: 2001

Squamous cell carcinoma
Source: International Congress 2015 – Lung cancer pathology
Year: 2015



Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006

Karyometric analysis of squamous metaplasia, dysplasia and squamous cell carcinoma of the lung
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Mutant P53 expression in squamous cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002

MEK5 promotes lung adenocarcinoma
Source: Eur Respir J, 53 (2) 1801327; 10.1183/13993003.01327-2018
Year: 2019



Expression of CD44v5 in epidermoid lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005

Management of EGFR mutated nonsmall cell lung carcinoma patients
Source: Eur Respir J 2015; 45: 1132-1141
Year: 2015



HER-2/neu overexpression in patients with lung carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003

Telomerase vs CD34 and MIB1 in non small cell lung cancer
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008


The role of TTF-1 in differentiation of primary and metastatic adenocarcinomas of the lung
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Aberrant methylation of p16 tumour suppresor gene and DAP kinase in nonsmall cell lung carcinomas
Source: Eur Respir J 2001; 18: Suppl. 33, 233s
Year: 2001

Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement
Source: Eur Respir J 2007; 30: 21-26
Year: 2007